Medical Research News and Research

RSS

AAN, Wolters Kluwer Health announce launch of Neurology Today for the iPad

The American Academy of Neurology (AAN) and Wolters Kluwer Health today announced the launch of Neurology Today for the iPad, a digital app of the most widely read newspaper for neurologists.

10 Jan 2012

Wolters Kluwer Health announces release of Oncology Times app for the iPad

Wolters Kluwer Health announced today the release of Oncology Times app for the iPad. Now cancer care professionals and others can access the latest oncology news and trends with the dynamic new Oncology Times app. Oncology Times is published by Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health.

10 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012

The Lancet announces first iPad app for healthcare professionals

The Lancet, the world's leading independent general medical journal, today announced its first app for iPad is now available on the App Store. The Lancet App is an innovative article-based navigation app that makes it easier for healthcare professionals (HCPs) to find the information they need quickly and efficiently from the convenience of their iPad.

7 Jan 2012

Poor nutrition in the womb can increase risk of type 2 diabetes in later life

Researchers funded by the Biotechnology and Biological Sciences Research Council have shown one way in which poor nutrition in the womb can put a person at greater risk of developing type 2 diabetes and other age-related diseases in later life.

7 Jan 2012

Many Americans support investment in health research: Poll

The new edition of America Speaks, a compilation of public opinion polls commissioned by Research!America, demonstrates increasing public support for research and innovation to improve health, create jobs and boost the economy. However, nearly 60% of Americans don't believe we are making enough progress in medical research, and 54% don't believe the U.S. has the best health care system in the world.

6 Jan 2012

Researchers discover that flatworm lacks centrosome

A tiny, freshwater flatworm found in ponds and rivers around the world that has long intrigued scientists for its remarkable ability to regenerate has now added a new wrinkle to biology.

6 Jan 2012

Novel vaccine combinations can protect against infection by SIV

Results from a recent study show that novel vaccine combinations can provide partial protection against infection by Simian Immunodeficiency Virus (SIV) in rhesus monkeys.

5 Jan 2012

IARS celebrates 90 years of support of anesthesia-related research

The International Anesthesia Research Society (IARS), the oldest professional society for anesthesiologists, originally founded as the National Anesthesia Research Society, celebrates 90 years of support of medical research in 2012.

5 Jan 2012

School nurses are among the casualties of tough fiscal times

In a pair of stories, NPR reports on how tight budgets are playing out with staff reductions for full-time school nurses and how hospitals and medical schools are marketing themselves.

5 Jan 2012

RGS9-2 gene plays a role in regulating body weight

Abraham Kovoor was studying a brain protein, called RGS9 2, that he had previously related to the involuntary, random and repetitive body movements that are side effects of drugs used to treat Parkinson's disease and schizophrenia.

5 Jan 2012

MRC-funded study to explore pancreatic cancer

A promising line of attack against pancreatitis and pancreatic cancer is to be explored further at Cardiff University, thanks to substantial new funding from the Medical Research Council.

4 Jan 2012

Scientists discover chemical compound that inhibits poxviruses from replicating

A team of scientists from Boston University School of Medicine (BUSM) have identified a novel compound that inhibits viruses from replicating. The findings, which are published online in the Journal of Virology, could lead to the development of highly targeted compounds to block the replication of poxviruses, such as the emerging infectious disease Monkeypox.

4 Jan 2012

Researchers evaluate sexual activity and satisfaction in older women

A new study of sexually active older women has found that sexual satisfaction in women increases with age and those not engaging in sex are satisfied with their sex lives. A majority of study participants report frequent arousal and orgasm that continue into old age, despite low sexual desire.

3 Jan 2012

Smokers prefer cold turkey - launch of study into quitting smoking including popular cold turkey method

Cold turkey is the preferred method for giving up smoking according to public health researchers at the University of Sydney. With more than two-thirds of smokers giving up permanently this way the research team wants to know why.

2 Jan 2012

Soon therapies may be guided by genetic blueprints

In a futuristic bid the doctors have drawn up plans to sequence the full genetic code of thousands of people in a landmark project to personalize their medical care. Each person will have all 6 billion letters of their genome read, stored and linked to their medical records to help doctors prescribe more effective drugs and other therapies.

1 Jan 2012

Research!America calls for stronger investment in medical research by elected officials

Research!America Chair John Edward Porter today called on elected officials to make a stronger investment in medical research in the new year to improve the health of Americans, maintain the nation's global competitiveness and boost the economy.

30 Dec 2011

Avastin fails to live up to expectations for extending survival in ovarian cancer

Cancer drug Avastin has been found to add about four months to the time it takes for the cancer to worsen for women with advanced cases of ovarian cancer says a new report. However it may not extend survival significantly.

29 Dec 2011

Bevacizumab delays disease progression in ovarian cancer

Treating ovarian cancer with the drug bevacizumab ("Avastin") delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK.

29 Dec 2011

Research provides first proof of epigenetic risk factor for type 2 diabetes

Research carried out at the Hebrew University of Jerusalem has provided the first proof of molecular risk factors leading to type 2 diabetes, providing an "early warning" sign that could lead to new approaches to treating this and other human disease conditions.

28 Dec 2011